SP1 and NFY Regulate the Expression of PNPT1 , a Gene Encoding a Mitochondrial Protein Involved in Cancer.
Ignacio VenturaFernando RevertFrancisco Revert-RosLucía Gómez-TatayJesús A Prieto-RuizJosé Miguel Hernández-AndreuPublished in: International journal of molecular sciences (2022)
The Polyribonucleotide nucleotidyltransferase 1 gene ( PNPT1 ) encodes polynucleotide phosphorylase (PNPase), a 3'-5' exoribonuclease involved in mitochondrial RNA degradation and surveillance and RNA import into the mitochondrion. Here, we have characterized the PNPT1 promoter by in silico analysis, luciferase reporter assays, electrophoretic mobility shift assays (EMSA), chromatin immunoprecipitation (ChIP), siRNA-based mRNA silencing and RT-qPCR. We show that the Specificity protein 1 (SP1) transcription factor and Nuclear transcription factor Y (NFY) bind the PNPT1 promoter, and have a relevant role regulating the promoter activity, PNPT1 expression, and mitochondrial activity. We also found in Kaplan-Meier survival curves that a high expression of either PNPase, SP1 or NFY subunit A (NFYA) is associated with a poor prognosis in liver cancer. In summary, our results show the relevance of SP1 and NFY in PNPT1 expression, and point to SP1/NFY and PNPase as possible targets in anti-cancer therapy.
Keyphrases
- poor prognosis
- transcription factor
- long non coding rna
- binding protein
- cancer therapy
- gene expression
- dna methylation
- oxidative stress
- genome wide
- high throughput
- public health
- crispr cas
- dna binding
- copy number
- dna damage
- squamous cell carcinoma
- papillary thyroid
- protein protein
- circulating tumor cells
- small molecule